World-first clinical trial targets immune molecule IL23 as potential treatment for sarcoma


Sydney researchers are testing whether an existing medication could be repurposed to treat sarcoma.

Read more

Rethink prompted on immediate cord clamping for pre-term babies


New study to influence clinical practice globally Changing how pre-term babies' umbilical cords are clamped could improve outcomes and save babies lives, prompting an update of the international guidelines that inform global practice.

Read more

CTC Director to lead promising new COVID-19 study


The CLARITY 2.0 study looks at the Dimerix lead candidate DMX-200 combined with Angiotensin Receptor Blockers to treat respiratory issues associated with COVID-19. The study will recruit patients at an early stage of respiratory complications, prior to the onset of Acute Respiratory Distress Syndrome (ARDS).

Read more

Nurse-led care helping Indigenous diabetes


Trained nurse and PhD candidate, Sharon Atkinson-Briggs, has made a huge impact on the prevention and management of diabetes-related eye damage in the Indigenous community in regional Victoria.

Read more

ENZAMET Trifecta


ENZAMET scooped the pool at the ACTA Trial of the Year Awards Ceremony winning the 2020 ACTA Trial of the Year Award, the ACTA STInG Award for Excellence in Trial Statistics and the Consumer Involvement Award. A fantastic achievement and the first trial to win all three awards!

Read more

New Director to lead CTC


We are very pleased to officially welcome Professor Meg Jardine to the CTC to lead the centre into its next phase of growth and development.

Read more

Quality of life for breast cancer patients


On the inaugural World Evidence-Based Healthcare Day, we look back at the successful SNAC (Sentinel Node Biopsy Versus Axillary Clearance) trial to remember the impact it has had on the treatment of women with early breast cancer.

Read more

Cannabis found to benefit chemotherapy patients


Researchers found cannabis could help reduce nausea and vomiting, two common and debilitating side effects of chemotherapy.

Read more

Vic's peak probably already passed


Victoria's number of COVID-19 cases is likely to have peaked late July.

Read more

CTC-led paper shows rise in gout worldwide


The CTC’s Dr Emma Smith was senior author on a paper that found gout cases have risen up to 20% in Australia in the last 20 years.

Read more

Tackling diabetes


The CTC is part of a university wide effort to tackle diabetes.

Read more

Our contribution to COVID-19


The CTC is calling on its research expertise to help bolster responses to COVID-19.

Read more

TheraP featured on CH9


CTC is collaboraing with ANZUP on a world first treatment for prostrate cancer.

Read more

CTC paper shows COVID-19 disaster averted


A data analytics study from the CTC's Prof Ian Marschner suggests the timing of COVID-19 restrictions in Australia stopped a significant growth in infections.

Read more

How to recruit for a trial


Following a successful recruitment strategy for the T4DM trial, Karen Bracken shares her lessons learned when recruiting for a trial.

Read more

CTC tells ABC more random sampling needed


Our Biostatistics Director, Prof Ian Marschner, tells ABC random sampling across geographies is just as important as hot spot testing in determining infection rates.

Read more

CTC is open during COVID-19


The vast majority of staff are working from home to ensure clinical trial research can continue.

Read more

Early start key to combating childhood obesity


On World Obesity Day, a new study shows that early education and support for pregnant women and parents could be key to combating rising rates of obesity in Australian kids.

Read more

Prof John Simes awarded AO


On Australia Day, Director of the CTC, Prof John Simes, received an Order of Australia award (AO) for his service to cancer research and clinical trials

Read more

CTC staff pick up Uni data and supervisor awards


CTC’s Medidata Implementation team and our Health Economics head, A/Prof Rachael Morton, received two coveted awards from the University for 2019.

Read more

Biostats discipline needs fostering in big data era


Australian medical research is at risk of punching below its weight unless more attention is paid to the discipline of biostatistics.

Read more

High class ACTA outing


CTC staff shined in the recent Australian Clinical Trials Alliance conference.

Read more

New CRE supporting innovative trials


The CTC will perform a key role in a newly announced Centre of Research Excellence (CRE) in clinical trials methodology.

Read more

Prof Stockler receives MOGA cancer achievement award


The CTC’s Prof Martin Stockler has received the prestigious MOGA Novartis Cancer Achievement Award for his outstanding contribution to medical oncology in Australia.

Read more

Back of eye holds secrets for people with diabetes


A new trial being undertaken by the NHMRC Clinical Trials Centre is photographing the back of the eye of those living with diabetes to help them avoid losing their vision and the risks of amputation and heart disease.

Read more

ENZAMET highlight at top US conference


The ANZUP-led ENZAMET trial was a stand-out success story at the recent American Society of Clinical Oncology annual conference.

Read more

Consumer partnership wins inaugural ACTA award


CTC’s partnership with Miracle Babies Foundation - a consumer body representing parents of sick newborns - has received the Australian Clinical Trials Alliance’s inaugural award for consumer engagement.

Read more

Pioneering the recruitment of preterm babies


In a long awaited study on preterm babies, the CTC and its partners have taken a pioneering path to ensure they get enough trial participants and can positively impact babies lives around the word.

Read more

Statins found to be safe and effective for the elderly


Statin therapy is safe and effective in older people over 75 years and reduces major cardiovascular events such as heart attacks and strokes, according to new research by the University of Sydney's Clinical Trials Centre published in The Lancet.

Read more

CTC investigators awarded new funding


Eleven CTC investigators were awarded new funding from the NHMRC, the ARC, the MRFF, Cure Brain Cancer, and the Danish Diabetes Academy.

Read more

Leading role in EU migration report


CTC leads review of cost-effectiveness for screening and vaccinating migrants for European Union.

Read more

New ways to kill pancreatic cancer


Pancreatic cancer could be treated using a new form of radiotherapy that delivers highly targeted doses of radiation to kill tumour cells.

Read more

Prof Tony Keech receives Vice Chancellor's Award


The award was established to celebrate exceptional performance at the University of Sydney.

Read more

Young neuro cancer patients get $1m boost


The Cooperative Trials Group for Neuro-Oncology (COGNO) at the CTC was awarded funding from CanTeen to give adolescent and young adult cancer patients access to the latest in treatment.

Read more

Lancet review calls for access to diabetes tools


In a recent review article, the CTC joins calls for better access to blood glucose meters and test strips for diabetes sufferers.

Read more

CTC Fellow wins Peter Bancroft Award


Congratulations to the CTC's Mbathio Dieng, who won a prestigious University of Sydney Faculty of Medicine Award for her PhD research into managing stress and fear of cancer recurrence in recovering, early-stage melanoma patients.

Read more

Neonatal team takes out premier ACTA award


A life-saving placental transfusion study led by CTC's Professor William Tarnow-Mordi received the Australian Clinical Trials Alliance 'Trial of the Year' Award.

Read more

Trial benefits exceed costs: report


A report authored by ACTA and an Australian Commission says trials return $5.80 for every $1 invested.

Read more